| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/16/2005 | US20050129761 Pantoprazole multiparticulate formulations |
| 06/16/2005 | US20050129760 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
| 06/16/2005 | US20050129758 Dietary fiber delivery system |
| 06/16/2005 | US20050129756 UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient |
| 06/16/2005 | US20050129755 Ingestible capsules containing ethanol |
| 06/16/2005 | US20050129754 Halogenated anesthetic in emulsion with lecithin |
| 06/16/2005 | US20050129753 Protonation therapy agent; transdermal gradient; complex of gluconic acid, ammonium compound and adriamycin |
| 06/16/2005 | US20050129752 Mammal therapy for pancreatic cancer |
| 06/16/2005 | US20050129750 Process for producing liposome suspension and product containing liposome suspension produced thereby |
| 06/16/2005 | US20050129749 Multi-layer transdermal drug delivery device |
| 06/16/2005 | US20050129748 Multilayer transdermal laminate patch with backing, adhesive |
| 06/16/2005 | US20050129739 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 06/16/2005 | US20050129738 Infant formula supplemented with phospholipids |
| 06/16/2005 | US20050129737 Devices and methods for pain management |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | US20050129732 Biodegradable, antibiotic, controlled release tape |
| 06/16/2005 | US20050129731 Polysulfone coating containing antiproliferative agents, antiinflammatory agents; antiphlogistic agent, anticoagulants; stents for prevent restenosis |
| 06/16/2005 | US20050129728 A mini-implant including a silicone support material, at leaast one drug and carrier in or on a silicone support rod; the mini-implant providing a predetermined threshold blood level of pharmaceutical active for treatment of a selected indication;improved drug carrying capacity |
| 06/16/2005 | US20050129724 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions |
| 06/16/2005 | US20050129723 Skin care composition that mediates cell to cell communication |
| 06/16/2005 | US20050129719 Concentrated emulsion formulation for silatecan |
| 06/16/2005 | US20050129710 Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids |
| 06/16/2005 | US20050129708 A mixture of Agaricus powder and a fucoidan-based polysaccharide composite extracted from wakame sprouts; hypoglycemic agents |
| 06/16/2005 | US20050129694 At least one (SEK) kinase inhibitor that acts in an synergistic manner to those inhibiting the virus multiplication for the Raf/MEK/ERK signal transmission path; influenza viricides |
| 06/16/2005 | US20050129679 By use of antagonists to JAM-1 Claudin-4 and occludin; drug delivery |
| 06/16/2005 | US20050129677 Altering the degree of internalization of the toxin; preventing or treating botulinum toxin intoxication; treating metabolic disorders, muscular disorders, nervous system disorders, and/or pain conditions |
| 06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
| 06/16/2005 | US20050129659 Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections |
| 06/16/2005 | US20050129657 Interferon-alpha induced gene |
| 06/16/2005 | US20050129655 Methods for preparing polymeric buffer formulations for electrotransport applications |
| 06/16/2005 | US20050129635 Novel heterocyclic derivatives of 2-oxothiazolidine-4-carboxylic acid, and use as active photoprotective agents |
| 06/16/2005 | US20050129624 Methods of treating conditions with a metal-containing material |
| 06/16/2005 | US20050129623 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
| 06/16/2005 | US20050129622 Nasal composition comprising a mucopolysaccharide and propylene glycol |
| 06/16/2005 | US20050129621 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 06/16/2005 | US20050129620 Treating an elastomeric substrate in an alcohol and an alkaline bath with ultrasonic energy, rinsing, drying; seals and gaskets for pharmaceutical inhalation devices, metered dose inhalers |
| 06/16/2005 | US20050129610 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
| 06/16/2005 | US20050126886 Method and apparatus for transferring substrates |
| 06/16/2005 | DE60103627T2 SELBSTEMULGIERENDES ARZNEISTOFFVERABREICHUNGSSYSTEM, wobei das Fettmittel optional ist A self-DRUG ADMINISTRATION SYSTEM, wherein the fat means is optional |
| 06/16/2005 | DE19916419B4 Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose Combination preparation of vitamin D metabolites or vitamin D analogs and a Östrogenpartialagonisten for the treatment of osteoporosis |
| 06/16/2005 | DE10355715A1 Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend Drug combinations creatine and / or creatine derivatives and / or creatinine and / or Kreatininderivaten and an effective amount of retinoids, retinol and retinyl palmitate in particular and preparations such active ingredient combinations |
| 06/16/2005 | DE10355711A1 Kosmetische und dermatologische Emulsionen, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen, einer Ionenstärke von mindestens 50 mmol/l Cosmetic and dermatological emulsions comprising creatine and / or creatinine and electrolyte concentrations, an ionic strength of at least 50 mmol / l |
| 06/16/2005 | DE10353535A1 Combination comprises benfotiamine, a chromium salt and folic acid, useful e.g. for improving impaired metabolism, especially in diabetics |
| 06/16/2005 | DE10352511A1 Verwendung von MRP4-Inhibitoren zur Behandlung und/oder Prophylaxe kardiovaskulärer Erkrankungen Use of MRP4-inhibitors for the treatment and / or prophylaxis of cardiovascular diseases |
| 06/16/2005 | DE10352449A1 Product for preventing or treating Alzheimer's disease comprises sphingomyelin and/or an activator of endogenous sphingomyelin synthesis and/or an inhibitor of endogenous sphingomyelin degradation |
| 06/16/2005 | DE10352137A1 Verwendung sulfatierter Hyaluronsäure Use of sulfated hyaluronic acid |
| 06/16/2005 | DE10351315A1 2-Phenyl-benzofuran-Derivate, Verfahren zur ihrer Herstellung und ihre Verwendung 2-phenyl-benzofuran derivatives, processes for their preparation and their use |
| 06/16/2005 | DE10351111A1 Arzneimittel und Verfahren zu ihrer Herstellung Pharmaceutical compositions and methods for their preparation |
| 06/16/2005 | DE10350929A1 Use of dispirotripiperazine derivatives to treat fungal infections or to prevent adhesion of fungi to surfaces |
| 06/16/2005 | DE10350194A1 Verwendung von Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen Use of Opuntia for the treatment of depressive disorders and diseases |
| 06/16/2005 | DE10349979A1 Medikamentöse gezielte lokale Lipolyse Drug targeted local lipolysis |
| 06/16/2005 | DE10349115A1 Kombinationspräparat zur Behandlung der Sepsis Combination treatment of sepsis |
| 06/16/2005 | CA2857067A1 Tubulin inhibitors |
| 06/16/2005 | CA2589908A1 Use of a cyclopentenone prostaglandin for delaying for the onset and/or preventing the continuation of labour |
| 06/16/2005 | CA2589528A1 Use of a cyclopentenone prostaglandin for delaying the onset and/or preventing the continuation of labour |
| 06/16/2005 | CA2582559A1 Treatment of hpv infections and cancer |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | CA2549225A1 Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride |
| 06/16/2005 | CA2549119A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
| 06/16/2005 | CA2548456A1 Combination therapy |
| 06/16/2005 | CA2548454A1 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 06/16/2005 | CA2548173A1 Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
| 06/16/2005 | CA2548129A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 06/16/2005 | CA2548127A1 Nitrooxyderivatives of antihypertensive drugs |
| 06/16/2005 | CA2548072A1 Inhalable tiotropium and container therefor |
| 06/16/2005 | CA2547955A1 Methods of preparing compounds useful as protease inhibitors |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/16/2005 | CA2547791A1 Therapeutics use of pyridinium compounds to modulate naadp activity |
| 06/16/2005 | CA2547782A1 Medical product containing tiotropium |
| 06/16/2005 | CA2547781A1 A medical product comprising tiotropium in a moisture-proof container |
| 06/16/2005 | CA2547780A1 Antisense compounds targeted to connexins and methods of use thereof |
| 06/16/2005 | CA2547774A1 Method for making pharmaceutical multiparticulates |
| 06/16/2005 | CA2547773A1 Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride |
| 06/16/2005 | CA2547759A1 Vanadium compounds as inhibitors of phosphatases |
| 06/16/2005 | CA2547670A1 Treating infectious diseases using ice inhibitors |
| 06/16/2005 | CA2547668A1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |
| 06/16/2005 | CA2547660A1 Method for administration of tiotropium |
| 06/16/2005 | CA2547657A1 Pharmaceutical compositions comprising lercanidipine |
| 06/16/2005 | CA2547652A1 Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal |
| 06/16/2005 | CA2547651A1 Anti-inflammatory agents |
| 06/16/2005 | CA2547639A1 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| 06/16/2005 | CA2547556A1 Developments in biologically active methylene blue derivatives (2) |
| 06/16/2005 | CA2547551A1 Diazabicyclononene and tetrahydropyridine derivatives with a new side-chain |
| 06/16/2005 | CA2547547A1 Diazabicyclononene derivatives and their use as renin inhibitors |
| 06/16/2005 | CA2547543A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia |
| 06/16/2005 | CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor |
| 06/16/2005 | CA2547245A1 Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 06/16/2005 | CA2547239A1 Azithromycin multiparticulate dosage forms by liquid-based processes |
| 06/16/2005 | CA2547229A1 Glycosylated triketide delta lactones |
| 06/16/2005 | CA2547212A1 Peroxisome proliferator activated receptor modulators |
| 06/16/2005 | CA2547171A1 Use of desoxypeganine for the treatment of schizophrenic psychoses |
| 06/16/2005 | CA2547077A1 Dna damage repair inhibitors for treatment of cancer |
| 06/16/2005 | CA2547066A1 Advanced indolinone based protein kinase inhibitors |
| 06/16/2005 | CA2547008A1 New class of gamma delta t cells activators and use thereof |
| 06/16/2005 | CA2546968A1 Food composition comprising glucosamine |
| 06/16/2005 | CA2546961A1 N-acyl-n'-benzyl-alkylendiamino derivatives |
| 06/16/2005 | CA2546959A1 Composition of herbal extracts for the treatment of atopic dermatitis, skin allergic conditions and acne |
| 06/16/2005 | CA2546950A1 Oral formulations of desoxypeganine and uses thereof |
| 06/16/2005 | CA2546926A1 Compositions for the treatment of afflictions of the oral cavity and upper respiratory tract |